2017
研究業績
Papers (English)
Original papers
1. Ae R, Hamaguchi T, Nakamura Y, Yamada M, Tsukamoto T, Mizusawa H, Belay ED, Schonberger LB. Update: dura mater graft-associated Creutzfeldt-Jakob disease — Japan, 1975-2017. Morbidity and Mortality Weekly Report (MMWR) (In Press)
2. Akagi A, Iwasaki Y, Mimuro M, Kitamoto T, Yamada M, Yoshida M. Pathological progression of genetic Creutzfeldt-Jakob disease with a PrP V180I mutation. Prion (In Press)
3. Ishida C, Ikeda T, Komai K, Takahashi K, Noguchi-Shinohara M, Yamada M. Contiguous and symmetrical disease expansion and massive necrosis of the cerebral white matter in a patient with neuromyelitis optica. Mult Scler J (In Press)
4. Ishimiya M, Nakamura H, Kobayashi Y, Noguchi Shinohara M, Abe C, Dohmoto C, Tokuno K, Ooi K, Yokokawa M, Iwasa K, Komai K, Kawashiri S, Yamada M. Tooth loss-related dietary patterns and cognitive impairment in an elderly Japanese population: the Nakajima Study. PLoS One (In Press)
5. Ito Y, Sanjo N, Hizume M, Kobayashi A, Ohgami T, Satoh K, Hamaguchi T, Yamada M, Kitamoto T, Mizusawa H, Yokota T. Biochemical features of genetic Creutzfeldt-Jakob disease with valine-to-isoleucine substitution at codon 180 on the prion protein gene. Biochem Biophys Res Commun (In Press)
6. Iwasa K, Yoshikawa H, Hamaguchi K, Sakai K, Noguchi-Shinohara M, Samuraki M, Takahashi K, Yanase D, Ono K, Ishida C, Yosita M, Nakamura H, Yamada M. Time-series analysis: variation of anti-acetylcholine receptor antibody titer in myasthenia gravis is related to incidence of Mycoplasma pneumoniae and influenza virus infections. Neurol Res (In Press)
7. Komatsu J, Sakai K, Nakada M, Iwasa K, Yamada M. Long spinal cord lesions in a patient with pathologically proven multiple sclerosis. J Clin Neurosci 42:106-108, 2017
8. Komatsu J, Matsunari I, Samuraki M, Shima K, Noguchi-Shinohara M, Sakai K, Hamaguchi K, Ono K, Matsuda H, Yamada M. Optimization of DARTEL settings for the detection of Alzheimer’s disease. Am J Neuroradiol (AJNR) (In Press)
9. Kovacs GG, Xie SX, Lee EB, Robinson JL, Irwin DJ, Toledo JB, Johnson VE, Smith DH, Caswell C, Alafuzoff I, Attems J, Bencze J, Bieniek KF, Bigio EH, Bodi I, Budka H, Dickson DW, Dugger BN, Duyckaerts C, Ferrer I, Forrest SL, Gelpi E, Gentleman SM, Giaccone G, Grinberg LT, Halliday GM, Hatanpaa KJ, Hof PR, Hofer M, Hortobágyi T, Ironside JW, King A, Kofler J, Kövari E, Kril1 JJ, Love S, Mackenzie IR, Mao Q, Matej R, McLean C, Munoz DG, Murray ME, Neltner J, Nelson PT, Ritchie D, Rodriguez RD, Rohan Z, Rozemuller A, Sakai K, Schultz C, Seilhean D, Smith V, Tacik P, Takahashi H, Takao M, Thal RD, Weis S, Wharton SB, White III CL, Woulfe JM, Yamada M, Trojanowski JQ. Multisite assessment of aging-related tau astrogliopathy (ARTAG). J Neuropathol Exp Neurol 76:605-619, 2017
10. Maruta T, Oshima M, Mosier DR, Atassi MZ. Injection of inactive Bordetella pertussiss and complete Freund’s adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice. Autoimmunity 50:293-305, 2017
11. McKeith I, Boeve B, Dickson D, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard C, Bayston A, Beach T, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda J, El-Agnaf O, Feldman H, Ferman T, Ffytche D, Fujishiro H, Galasko D, Graff-Radford N, Goldman J, Gomperts S, Honing L, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee V, Leverenz J, Lippa C, Lewis S, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine T, Moreno E, Mori E, Murray M, O’Brien J, Orimo S, Postuma R, Ramaswamy S, Ross O, Salmon D, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo J, Trojanowski J, Tsuang D, Walker Z, Yamada M, Kosaka K. Recommendations for the diagnosis and management of dementia with Lewy bodies. Fourth consensus report of the DLB consortium. Neurology 89:88-100, 2017
12. Muroishi T, Sakai K, Yanase D, Ikeda Y, Machiya T, Kato-Motozaki Y, Samuraki M, Yamada M. Serum anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder presenting as acute eosinophilic encephalomyelitis. J Clin Neurosci (In Press)
13. Nakajima K, Okuda K, Yokoyama K, Yoneyama T, Tsuji S, Oda H, Yoshita M, Kubota K. Cross calibration of 123I-meta-iodobenzylguanidine heart-to-mediastinum ratio with D-SPECT planogram and Anger camera. Ann Nucl Med 31:605-615, 2017
14. Nakamura K, Hamaguchi T, Sakai K, Noto D, Ono K, Hayashi Y, Nishino I, Yamada M. Granuloma formation in a patient with GNE myopathy: a case report. Neuromuscul Disord 27:183-184, 2017
15. Nakamura K, Hamaguchi T, Yamada M. Demyelinating polyneuropathy after long-term treatment with infliximab. Int J Rheum Dis 20:1781-1782, 2017
16. Nakanishi K, Jin Z, Homma S, Elkind MS, Rundek T, Tugcu A, Yoshita M, DeCarli C, Wright CB, Sacco RL, Di Tullio MR. Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions (CABL) study. Am Heart J 185:85-92, 2017
17. Nakanishi K, Jin Z, Homma S, Elkind MS, Rundek T, Lee CS, Tugcu A, Yoshita M, DeCarli C, Wright CB, Sacco RL, Di Tullio MR. Association between heart rate and subclinical cerebrovascular disease in the elderly. Stroke (In Press)
18. Nakano H, Sakai K, Iwasa K, Yamada M. Cervical fexion myelopathy eleven years after a cervical cord injury. Intern Med 56:2213-2215, 2017
19. Nakano H, Yanase D, Mae K, Toribatake Y, Yamada M. Succesful antibacterial therapy of a spinal epidural abscess in pregnancy: a case report of review of the literature. J Neurol Sci 372:101-103, 2017
20. Noguchi-Shinohara M, Komatsu J, Samuraki M, Matsunari I, Ikeda T, Sakai K, Hamaguchi T, Ono K, Nakamura H, Yamada M. Cerebral amyloid angiopathy-related microbleeds and CSF biomarkers in Alzheimer’s disease. J Alzheimers Dis 55:905-913, 2017
21. Oshima M, Iida-Klein A, Maruta T, Deitiker PR, Atassi MZ. Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice. Autoimmunity 50:346-353, 2017
22. Sakai K, Asakawa M, Takahashi R, Ishida C, Nakamura R, Hamaguchi T, Ono K, Iwasa K, Yamada M. Coexistence of transthyretin- and Aβ-type cerebral amyloid angiopathy in a patient with hereditary transthyretin V30M amyloidosis. J Neurol Sci 381:144-146, 2017
23. Sakai K, Ishida C, Motozaki Y, Tagami A, Komai K, Yamada M. Somatic sprouts of the Purkinje cells in a patient with multiple system atrophy. Neuropathology (In Press)
24. Sakashita Y, Hamada T, Machiya T, Yamada M. Acute intermittent porphyria presenting as posterior reversible encephalopathy syndrome with hyperperfusion in bilateral occipital lobes: a case report. J Neurol Sci 377:47-49, 2017
25. Samuraki M, Sakai K, Odake Y, Yoshita M, Misaki K, Nakada M, Yamada M. Multiple sclerosis with elevated levels of adenosine deaminase in the cerebrospinal fluid. Mult Scler Relat Disord 13:44-46, 2017
26. Sekijima Y, Yazaki M, Ueda M, Koike H, Yamada M, Ando Y. First nationwide survey on systemic wild-type ATTR amyloidosis in Japan. Amyloid (In Press)
27. Shimizu T, Ishikawa-Takata K, Sakata A, Nagaoka U, Ishihara N, Ishida C, Nakayama Y, Komori T, Nishizawa M. The measurement and estimation of total energy expenditure in Japanese patients with ALS: a doubly labeled water method study. Amyotroph Lateral Scler Frontotemporal Degener 18:37-45, 2017
28. Wright CB, Dong C, Perez EJ, De Rosa J, Yoshita M, Rundek T, DeCarli C, Gutierrez J, Elkind MSV, Sacco RL. Subclinical cerebrovascular disease increases the risk of incident stroke and mortality: The Northern Manhattan Study. J Am Heart Assoc 6:e004069, 2017
29. Yuki-Nozaki S, Noguchi-Shinohara M, Domoto C, Ikeda Y, Samuraki M, Iwasa K, Yokogawa M, Asai K, Komai K, Nakamura H, Yamada M. Differences in dementia beliefs between non-demented public screeners and in-home screeners and their potential impact on future dementia screening intention: the Nakajima Study. J Alzheimers Dis (In Press)
Reviews
1. Takamori M. Synaptic homeostasis and its immunological disturbance in neuromuscular junction disorders. Int J Mol Sci 18:896, 2017
2. Takamori M. Pathogenic par cipa on of musk-biglycan linkage contribu ve to synaptic stability and signalings in myasthenia gravis. J Autoimmune Disord 3:41, 2017
Invited lectures
1. Hamaguchi T, Yamada M. Transmission of amyloid β protein. Asian Pacific Prion Symposium (APPS2017), Melbourne, October 20-21, 2017
2. Yamada M, Hamaguchi T, Sakai K, Noguchi-Shinohara M, Nozaki I, Taniguchi Y, Kobayashi A, Takeuchi A, Kitamoto T, Nakamura Y, Sanjo N, Tsukamoto T, Takao M, Murayama S, Iwasaki Y, Yoshida M, Shimizu H, Kakita A, Takahashi H, Suzuki H, Naiki H, Mizusawa H. Iatrogenic Creutzfeldt-Jakob disease related to dura mater grafts. PRION2017, Edinburgh, May 23-26, 2017
3. Yamada M. Pathological and molecular heterogeneity of “clinically probable Alzheimer’s disease”. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
Presentations
1. Adachi A, Yoshikawa H. Features of the total health support system of universities in the United States- cultural differences from a foreigner’s standpoint. 2017 ACHA Annual Meeting, Austin, June1-2, 2017
2. Furukawa F, Kitamoto T, Nakamura Y, Yamada M, Tsukamoto T, Mizusawa H, Yokota T, Sanjo N. Clinicopathological features of Gerstmann-Straüssler-Scheinker syndrome with P105L mutation. PRION2017, Edinburgh, May 23-26, 2017
3. Furukawa F, Ae R, Nakamura Y, Hamaguchi T, Yamada M, Tsukamoto T, Mizusawa H, Yokota T, Sanjo N. Analysis of clinical features of patients with lower limb muscle weakness in GSS with P102L mutation. Asian Pacific Prion Symposium (APPS2017), Melbourne, October 20-21, 2017
4. Hamaguchi T, Sakai K, Kobayashi A, Kitamoto T, Ae R, Nakamura Y, Sanjo N, Tsukamoto T, Mizusawa H, Yamada M. Clinical and pathological characterization of “sporadic Creutzfeldt-Jakob disease” with histories of neurosurgery to identify iatrogenic cases. PRION2017, Edinburgh, May 23-26, 2017
5. Hamaguchi T, Sakai K, Kobayashi A, Kitamoto T, Ae R, Nakamura Y, Sanjo N, Arai K, Koide M, Katada F, Tsukamoto T, Mizusawa H, Yamada M. Investigation of clinical and pathological features of “sporadic Creutzfeldt-Jakob disease” with history of neurosurgery to identify iatrogenic cases. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
6. Hayashi K, Kanemoto M, Sakai K, Endo K, Ueno T, Yamada M. Taste disturbance in hereditary transthyretin amyloidosis. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
7. Ishida C, Motozaki Y, Takahashi K, Ikeda T, Asakawa M, Komai K. Clinical course of the patients with spinocerebellar ataxia type 3/Machado-Joseph disease in the Hokuriku district in Japan. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
8. Iwasa K, Yoshikawa H, Hamaguchi T, Sakai K, Shinohara-Noguchi M, Samuraki M, Takahashi K, Yanase D, Ono K, Ishida C, Yoshita M, Nakamura H, Yamada M. Correlations between the time trends of anti-acetylcholine receptor antibody titer variation in myasthenia gravis and the incidence of Mycoplasma and influenza infections. 13th International Conference on Myasthenia Gravis and Related Disorders, New York, May 15-17, 2017
9. Iwasa K, Yoshikawa H, Hamaguchi T, Sakai K, Shinohara-Noguchi M, Samuraki M, Takahashi K, Yanase D, Ono K, Ishida C, Yoshita H, Nakamura H, Yamada M. The time trends of anti-acetylcholine receptor antibody titer variation in myasthenia gravis is related to the incidence of Mycoplasma and influenza infections. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
10. Komai K, Tagami A, Ishida C, Takahashi K, Motozaki Y, Akagi A, Ozaki T, Shimizu A. Effectiveness of automatic intratracheal suctioning system for amyotrophic lateral sclerosis patients with tracheostomy-invasive ventilation. 69th Annual meeting of American Academy of Neurology, Boston, April 22-28, 2017
11. Komai K, Ishida C, Takahashi K, Tagami A, Motozaki Y, Ikeda T. A retrospective hospital-based prognosis study of pathologically proved Japanese amyotrophic lateral sclerosis. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
12. Komai K, Tagami A, Ishida C, Takahashi K, Motozaki Y, Akagi A, Ozaki T, Shimizu A. Automatic intratracheal suctioning system improved airway clearance of amyotrophic lateral sclerosis patients with tracheostomy-invasive ventilation. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
13. Komai K, Ishida C, Takahashi K, Tagami A, Motozaki Y, Ikeda T. Prognosis of pathologically confirmed Japanese amyotrophic lateral sclerosis, a retrospective institute-based study. 28th International Symposium on ALS/MND, Boston, December 8-10, 2017
14. Kuroiwa Y, Takumi I, Murai H, Kasuga K, Nakamura Y, Fujino K, Hirai T, Kawabata Y, Baba Y, Sato K, Harada M, Kitamoto T, Tsukamoto T, Yamada M, Mizusawa H. Periodic encephalographic study in nation-wide Creutzfeldt-Jakob disease surveillance in Japan. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
15. Miura Y, Nakamichi K, Kishida S, Hamaguchi T, Takahashi K, Hara Y, Ishibashi K, Matsumura K, Sanjou N, Suzuki T, Ae R, Nakamura K, Sawa H, Nagashima K, Nukuzuma S, Yukitake M, Saijou M, Mizusawa H, Yamada M. Clinical effect of mefloquine on progressive multifocal leukoencephalopathy: a large-scale study in Japan. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
16. Motozaki Y, Asakawa M, Ikeda T, Tagami A, Takahashi K, Ishida C, Komai K. Clinical prognosis of amyotrophic lateral sclerosis patients treated with non-invasive ventilation. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
17. Muramatsu D, Kanemoto M, Tada Y, Hayashi K, Nakano H, Sakai K, Yamada M. Cognitive dysfunction and hyperintensity signals on diffusion-weighted magnetic resonance imaging in patients with neuronal intranuclear inclusion disease. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
18. Nakano H, Ikeda T, Shimizu A, Ozaki T, Komatsu J, Nozaki I, Hamaguchi T, Iwasa K, Tanaka K, Yamada M. Total tau protein in cerebrospinal fluid as a prognostic marker in anti-N-methyl-D-aspartate receptor encephalitis. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
19. Narita T, Minami N, Niino M, Izaki S, Nomura K, Kawaguchi N, Murai H, Kira J, Shimizu J, Iwasa K, Yoshikawa H, Hatanaka Y, Sonoo M, Shimizu Y, Nomura Y, Matsuo H. Clinical features of ocular myasthenia gravis in Japan. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
20. Nozaki I, Neumann H, Mathews M, Kopatz J. Phagocytic function is reinforced by deletion of CD33 in human THP1 macrophages. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
21. Odake Y, Yoshita M, Hosokawa M. The polysomnography study of inpatients with severe neurodegenerative disorders. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
22. Ono K, Nakayama T, Itami M, Takahashi R, Teplow D, Yamada M. High-speed atomic force microscopy reveals structural dynamics of amyloid β1-42 aggregates. Alzheimer’s Association International Conference (AAIC) 2017, London, July 16-20, 2017
23. Ono K, Nakayama T, Itami M, Takahashi R, Teplow D, Yamada M. High-speed atomic force microscopy reveals structural dynamics of amyloid β1-42 aggregates. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
24. Sakai K, Hamaguchi T, Sanjo N, Murai H, Iwasaki Y, Hamano T, Honma M, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Kitamoto T, Mizusawa H, Yamada M. Type-dependent diverse extension patterns of hyperintensity on diffusion-weighted MR images in dura matter graft-associated Creutzfeldt-Jakob disease. PRION2017, Edinburgh, May 23-26, 2017
25. Sakai K, Hamaguchi T, Sanjo N, Murai H, Iwasaki Y, Hamano T, Honma M, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Kitamoto T, Mizusawa H, Yamada M. Diffusion-weighted MR images in dura mater graft-associated Creutzfeldt-Jakob disease. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
26. Sakajiri K, Nitta E. A retrospective study of headache accompanying Campylobacter enterocolitis. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
27. Shinohara M, Komatsu J, Samuraki M, Matsunari I, Ikeda T, Sakai K, Hamaguchi T, Ono K, Nakamura H, Yamada M. Associations between cerebral amyloid angiopathy-related microbleeds and cerebrospinal fluid biomarkers in Alzheimer’s diseasec. Alzheimer’s Association International Conference (AAIC) 2017, London, July 16-20, 2017
28. Tada Y, Hamaguchi T, Ikeda Y, Takahashi K, Yamada M. Multiple sclerosis and alopecia areata. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
29. Takahashi K. Lymphocyte subsets in the peripheral blood of fingolimod treated Japanese patients with multiple sclerosis. 3rd Congress of the European Academy of Neurology, Amsterdam, June 24-27, 2017
30. Takamatsu A, Sakajiri K, Nitta E. Examination of body lateropulsion of cerebral infarction. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
31. Tsukamoto T, Sanjo N, Hamaguchi T, Nakamura Y, Kitamoto T, Yamada M, Mizusawa H. CJD with M232R: Its clinicoepidemiological features. PRION2017, Edinburgh, May 23-26, 2017
32. Tsukamoto T, Sanjo N, Hamaguchi T, Nakamura Y, Kitamoto T, Yamada M, Mizusawa H, and Prion Disease Surveillance Committee, Japan. Analysis of cases in which prion disease was denied by the Prion disease Surveillance Committee in Japan in 2016. Asian Pacific Prion Symposium (APPS2017), Melbourne, October 20-21, 2017
33. Wißfeld J, Nozaki I, Mathews M, Mossad O, Hornung V, Neumann H. Microglial Siglec-3/CD33. PHAGO 2nd General Assembly meeting, Paris, October 25-27, 2017
34. Yamada M, Hamaguchi T, Taniguchi Y, Sakai K, Kitamoto T, Takao M, Murayama S, Iwasaki Y, Yoshida M, Shimizu H, Kakita A, Takahashi H, Suzuki H, Naiki H, Sanjo N, Mizusawa H. Possible human-to-human transmission of cerebral β-amyloidosis via cadaveric dura mater grafting. Alzheimer’s Association International Conference (AAIC) 2017, London, July 16-20, 2017
35. Yoshikawa H, Iwasa K, Adachi Y, Edahiro S, Maruta T, Furukawa Y, Yamada M, Matsui M. Ten-year chronological clinical profiles of myasthenia gravis in Japan -epidemiological analyses of the national database established by the policy of intractable diseases of Japan. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
36. Yoshikawa H, Iwasa K, Kawaguchi N, Kira J, Kohriyama T, Kuriyama N, Matsuo H, Minami N, Murai H, Niino M, Nomura K, Nomura Y, Ogino M, Shimizu Y, Sonoo M, Suzuki S, Takeuchi H, Matsui M. Assured diagnostic critera of myasthenia gravis by the task force for evidence-based diagnostic and therapeutic algorithms for the national policy of intractable diseases of Japan. XXⅢ World Congress of Neurology/58th Annual Meeting of the Japanese Society of Neurology, Kyoto, September 16-21, 2017
37. Yoshita M, Tsuji S, Yokoyama K, Sakamoto H. The incidence of dementia with Lewy bodies in suspected non-Alzheimer pathophysiology. Alzheimer’s. Association International Conference (AAIC) 2017, London, July 16-20, 2017
